SEHK Growth Companies With High Insider Ownership And Earnings Growth Up To 55%

Amid a backdrop of fluctuating global markets, Hong Kong's Hang Seng Index has recently shown resilience, climbing 2.64% as noted in recent updates. This positive momentum in the Hong Kong market sets an intriguing stage for examining growth companies with high insider ownership, which can be indicative of confidence from those closest to the company's operations and future prospects.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name	Insider Ownership	Earnings Growth
New Horizon Health (SEHK:6606)	16.6%	61%
iDreamSky Technology Holdings (SEHK:1119)	20.1%	104.1%
Meitu (SEHK:1357)	38%	34.3%
Adicon Holdings (SEHK:9860)	22.3%	29.6%
DPC Dash (SEHK:1405)	38.2%	91.5%
Tian Tu Capital (SEHK:1973)	34%	70.5%
Zhejiang Leapmotor Technology (SEHK:9863)	14.2%	74%
Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)	15.7%	100.1%
Ocumension Therapeutics (SEHK:1477)	17.7%	93.7%
Beijing Airdoc Technology (SEHK:2251)	26.4%	83.9%

Click here to see the full list of 52 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

LifeTech Scientific

Simply Wall St Growth Rating: ★★★★☆☆

Overview: LifeTech Scientific Corporation, an investment holding company, specializes in developing, manufacturing, and trading interventional medical devices for cardiovascular and peripheral vascular diseases globally, with a market capitalization of approximately HK$8.61 billion.

Operations: LifeTech Scientific's revenue is derived from three main segments: Structural Heart Diseases Business generating CN¥495.67 million, Peripheral Vascular Diseases Business contributing CN¥707.11 million, and Cardiac Pacing and Electrophysiology Business at CN¥64.40 million.

Insider Ownership: 17.4%

Earnings Growth Forecast: 20.5% p.a.

LifeTech Scientific, a growth company in Hong Kong with high insider ownership, is navigating through financial complexities with mixed results. While its revenue growth of 16.8% per year outpaces the local market's 8%, and earnings are expected to increase by 20.5% annually, recent financial statements show a decline in net income from CNY 325.34 million to CNY 263.24 million year-over-year due to non-recurring losses and increased expenses in share-based payments. Despite these challenges, no significant insider shares were purchased recently, reflecting potential caution among insiders about immediate growth prospects.

• Navigate through the intricacies of LifeTech Scientific with our comprehensive analyst estimates report here.

• Insights from our recent valuation report point to the potential overvaluation of LifeTech Scientific shares in the market.

SEHK:1302 Earnings and Revenue Growth as at May 2024

ESR Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: ESR Group Limited operates in logistics real estate development, leasing, and management across regions including Hong Kong, China, Japan, South Korea, Australia, New Zealand, Southeast Asia, India, Europe and internationally with a market capitalization of approximately HK$42.12 billion.

Operations: The company generates revenue primarily through fund management (HK$774.64 million) and new economy development (HK$105.48 million).

Insider Ownership: 12.9%

Earnings Growth Forecast: 26.3% p.a.

ESR Group, a Hong Kong-based logistics firm, shows promise with expected earnings growth of 26.3% annually, outperforming the local market forecast of 12%. However, its revenue growth at 9.1% is modest compared to industry giants. Recent financials reveal a profit margin drop from last year and challenges in covering interest payments with earnings. Amidst this, ESR is under potential privatization talks led by Warburg Pincus with an offer valued between US$7 billion and US$8 billion, suggesting strong insider confidence despite current financial hurdles.

• Click here to discover the nuances of ESR Group with our detailed analytical future growth report.

• Our comprehensive valuation report raises the possibility that ESR Group is priced lower than what may be justified by its financials.

SEHK:1821 Ownership Breakdown as at May 2024

Value Partners Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Value Partners Group Limited, a publicly owned investment manager, operates with a market capitalization of approximately HK$3.84 billion.

Operations: The firm generates its revenue primarily from its asset management business, totaling approximately HK$575.73 million.

Insider Ownership: 24.3%

Earnings Growth Forecast: 55.9% p.a.

Value Partners Group Limited, a notable entity in Hong Kong's financial sector, has recently undergone significant board changes, with new appointments potentially strengthening its strategic direction. The company turned profitable this year with a net income of HK$23.09 million after a substantial loss the previous year. It is expected to see robust annual earnings growth at 55.9% over the next three years, outpacing the local market projection of 12%. However, its forecasted revenue growth of 10.7% annually, while above the market average of 8%, does not reach hyper-growth status and Return on Equity is anticipated to remain low at 8.8% in three years' time.

• Click here and access our complete growth analysis report to understand the dynamics of Value Partners Group.

• Upon reviewing our latest valuation report, Value Partners Group's share price might be too optimistic.

SEHK:806 Earnings and Revenue Growth as at May 2024

Next Steps

• Dive into all 52 of the Fast Growing SEHK Companies With High Insider Ownership we have identified here.

• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include SEHK:1302 SEHK:806 and

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com